The Read: RYAM’s stock surged about 42% after Q4 2025 earnings met estimates with a positive 2026 outlook signaling demand recovery, but then fell about 5% when no specialty cellulose price hike was announced and a strategic review began, followed by a nearly 15% drop after a wider-than-expected Q1 loss overshadowed revenue beats despite early pricing progress.
Price
Overlays
Panel
RYAM
Hover to view data
No Data